Advisory Board and Editors Cardiology
Fatima Saqib
Dr. Fatima Saqib, has a PhD in Pharmacology from Bahauddin Zakariya University. Currently, she is serving as Professor (Assistant) in BZU, Multan. Previously she served as Lecturer for 8 years. She has supervised 34 M.Phil students and 5 PhD students under supervision. She has published 38 international research articles and review paper with a total IF120 with h-index 12, i-index 16 and total google scholar citations 437.
Ripon Sarkar
Ripon Sarkar is a dedicated researcher with over a decade of experience in cutting-edge technology in the fields of mitochondrial metabolism, cardiovascular disease, cancer biology and tissue engineering. Dr. Sarkar has demonstrated a profound commitment to advancing scientific knowledge and innovation.
Currently serving as a Postdoctoral Research Fellow at The UTHealth at Houston, Dr. Sarkar's research focuses on cardiovascular disease, especially on aortic and coronary artery disease to understand the molecular mechanism. His proficiency in these areas has been instrumental in conducting groundbreaking research and publishing his findings in reputable scientific journals. Throughout his academic and professional journey, Dr. Sarkar has been recognized with numerous honors and awards.
Dr. Sarkar's dedication to advancing scientific knowledge is further evidenced by his service to the community and his editorial contributions to various scientific journals. He is committed to leveraging his expertise to address pressing healthcare challenges and make meaningful contributions to society.
Teresa M Seccia
Associate Professor in Internal Medicine, Dept. Medicine, University of Padova, Italy.
International PhD Degree in 'Arterial Hypertension and Vascular Biology'.
Field of interest: Clinical and translational research in high blood pressure and cardiovascular diseases.
Consolato Sergi
Dr. Consolato M. Sergi is Chief of Anatomical Pathology of the Children's Hospital of Eastern Ontario, University of Ottawa, Ontario, Canada and Emeritus Professor of Pathology and Pediatrics of the University of Alberta, Canada. Dr. Sergi was born in Rome (Italy), obtained his MD degree with honors at the University of Genoa, Italy, his Human Pathology degree at the University of Heidelberg, Germany, the title of the hon. Clinical Reader of the University of Bristol, UK, his Ph.D./Habilitation at the University of Innsbruck, Austria, his MSc Public Health in Austria, and his FRCPC degree at the Royal College in Ottawa. Dr. Sergi’s specialty areas of interest are congenital heart disease and metabolic diseases, obstructive cholangiopathies, carcinogenesis (bone/soft tissue/liver), gut microbiome, and mitochondrial DNA related cardiomyopathies.
Gaurav Sharma
Gaurav Sharma is a biomedical researcher with expertise in intermediary metabolism and metabolic imaging. His long-term research interests are the development of magnetic resonance spectroscopy/imaging (MRS/I) techniques for the noninvasive investigation of metabolic processes under both normal and pathologic conditions that can be applied in preclinical and clinical settings. Gaurav's current research focus is mainly in two areas: first, development of novel methods for non-invasive assessment of metabolism and second, understanding the intermediary metabolism in biological systems. In particular, his research involved the use of dynamic nuclear polarization to increase the MR signal of metabolically active, 13C-labeled probes for accessing metabolism in isolated perfused organs and in vivo metabolic imaging, and 13C-NMR isotopomer analysis for assessing in vivo metabolic flux.
Jeremy A. Simpson
Assistant Professor, University of Guelph. Editorial board, Frontiers in Respiratory Physiology
Edward R Smith
Professor Edward Smith is an Associate Professor in the Department of Medicine, University of Melbourne and Senior Scientist at the Kincaid-Smith Renal Laboratories, Department of Nephrology, The Royal Melbourne Hospital. He is interested in mineral metabolism and kidney disease.
Ashish K Solanki
My Ph.D. (Structural Biology/Biochemistry) focused on studying the pathogenesis of the HIV-1 virus and finding ways to combat its infection. It included structural analysis of the interaction of HIV-1 gp120 with neutralizing and non-neutralizing mAbs, chimeric antibody-CD4 IgG2, and with the host cell surface glycoprotein CD4. Although in the past I have been working on structural, biophysical, and biochemical methods to answer some of the critical questions in biology, my interest in cell signaling and protein trafficking enabled me to join the Dept. of Nephrology, MUSC, South Carolina as a postdoctoral fellow. I have gained a large amount of experience in the field of protein biochemistry and substantial knowledge of podocyte biology during months spent as a postdoc. I explored the role of the exocyst complex in podocyte development and functions, critical aspects of cell signaling, studying pathophysiology and diseases progression caused by mutations in slit diaphragm proteins, which not only helped to get publications but increased my understanding in the field of podocyte biology. The understanding and development of animal model systems in the lab further helped me to strengthen my podocyte experience. I also worked on developing a novel cell-based assay to diagnose recurrent Focal and Segmental Glomerulosclerosis.
Dinesh C Voruganti
Dr. Dinesh Voruganti is a Cardiology Fellow at the University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. He is a clinical cardiology fellow with focussed interest in clinical research. Dr. Voruganti's expertise involves database based research.
Shibiao Wan
Dr. Shibiao Wan is currently an Assistant Professor in the Department of Genetics, Cell Biology and Anatomy at University of Nebraska Medical Center (UNMC). He is also the Assistant Director for Bioinformatics and Systems Biology Core at UNMC.
With more than 13 years of experience in machine learning, bioinformatics, and computational biology, Dr. Wan has published >40 articles in top-tiered journals such as Genome Research, Nature Communications, Science Advances, Circulation Research, Briefings in Bioinformatics, and Bioinformatics. Dr. Wan is the Editor-in-Chief for Current Proteomics, and an Editorial Board Member for a series of prestigious journals such as Briefings in Functional Genomics, BMC Bioinformatics, PeerJ Computer Science, BioMed Research International, and Computational and Mathematical Methods, and a guest associate editor for multiple high-impact journals including Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Frontiers in Pharmacology, Biology, Frontiers in Genetics, and Genes.
Dr Wan is a TPC member for >20 machine learning related international conferences including IEEE ICTAI. Dr. Wan is also a reviewer for >50 prestigious journals including Nature Computational Science, Nucleic Acids Research, Cancer Research, Genome Medicine, and Briefings in Bioinformatics. He is a recipient of the global peer review awards (top 1%) in “Cross-Field” and “Biology and Biochemistry” in 2019 awarded by Clarivate. Dr. Wan is also an Outstanding Young Alumni Awardee in 2021-2022. Dr. Wan is an IEEE Senior Member and a member of AACR, ISCB and ACM.
Timothy D. Warner
Dr. Warner graduated in pharmacology in 1986 from King’s College London. He then moved to the newly established William Harvey Research Institute to pursue his PhD studies under the supervision of Prof. Sir John Vane (Nobel Laureate, 1982) during which time he was awarded the Premier Prix Annuel de Recherche en Phlébologie. In 1989 he completed his PhD and went to pursue his post-doctoral studies with Ferid Murad (Nobel Laureate 1998) at Northwestern University and Abbott Laboratories, Chicago. He returned to the William Harvey Research Institute in 1992, being awarded a British Heart Foundation lectureship in 1995. He was promoted Reader in Pharmacology in 1999 and awarded a personal chair in Vascular Inflammation in 2000, at which time he was the recipient of the British Pharmacology Society’s Novartis Prize. He has been listed by the Instit. for Scientific Information among the top 0.5% of cited pharmacologists. Currently he is Dept. Dean for Research in the School of Medicine and Dentistry and Deputy Director (Research & Innovation) of QMUL’s Life Science Initiative and previously SMD Deputy Dean for Postgraduate Research. He is a Fellow of the British Pharmacological Society, the American Heart Association and the Society of Biology, he is also a member of the British Society for Cardiovascular Research, International Society for Hypertension Research and the International Society on Thrombosis and Haemostasis. He is currently principal editor of the journal ‘Platelets’.
Bernhard Wernly
Dr Bernhard Wernly is a Physician-scientist at the Paracelsus Medical University, Salzberg, Austria. He is trained in cardiology and intensive care medicine, MD, PhD and currently doing a Master in Public Health.